Sarah Ketterer
Causeway Capital Management
Causeway Capital Management 13F holdings
Sarah Ketterer's Portfolio
- Portfolio value:
- $3.79B≈
- # of securities:
- 89
- Reported for:
- 30 Sep 2023 (Q3)
- Latest filing date:
- 13 Nov 2023
What stocks did Sarah Ketterer own in 2023 Q3?
What was Sarah Ketterer's 2023 Q3 portfolio?
Causeway Capital Management has disclosed a total of 89 security holdings in their (2023 Q3) SEC 13F filing(s) with portfolio value of $3,788,892,678.
Causeway Capital Management's portfolio holdings are tracked quarterly based on SEC 13F filings. Snapshots for each reporting period document the full list of disclosed positions and their portfolio allocations.
Sarah Ketterer's original 13F reports (2023 Q3) are the official SEC institutional disclosure documents covering all reported equity positions.
89 results
| History | Ticker | Name |
% of portfolio |
Shares* |
Reported price* |
% difference current price* |
Value | Held since* | Held for* |
Security type |
% (shares) of activity |
% change to portfolio |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Sanofi ADR
|
0.68%
|
$53.64
|
-17.70%($44.14)
|
2020 Q2
|
≈ 3.50 years
|
Depositary Receipt
|
+29.18% (+108.57K)
|
||||
|
|
AstraZeneca PLC
|
0.63%
|
$67.72
|
|
2021 Q2
|
≈ 2.50 years
|
Depositary Receipt
|
+34.38% (+90.88K)
|
||||
|
|
Daqo New Energy Corp ADR
|
0.59%
|
$30.27
|
-59.97%($12.12)
|
2021 Q4
|
≈ 2.00 years
|
Depositary Receipt
|
-13.33% (-114.1K)
|
||||
|
|
iShares Core MSCI EAFE ETF
|
0.58%
|
$64.35
|
+49.57%($96.25)
|
2023 Q3
|
≈ 0.25 years
|
ETP
|
new
|
||||
|
|
Koninklijke Philips NV ADR
|
0.57%
|
$19.28
|
+40.06%($27.01)
|
2022 Q1
|
≈ 1.75 years
|
Depositary Receipt
|
-6.01% (-72.17K)
|
||||
|
|
GlaxoSmithKline PLC ADR
|
0.54%
|
$36.25
|
+42.14%($51.52)
|
2021 Q4
|
≈ 2.00 years
|
Depositary Receipt
|
+41.39% (+165.32K)
|
||||
|
|
Rio Tinto ADR
|
0.53%
|
$63.64
|
+42.65%($90.78)
|
2022 Q3
|
≈ 1.25 years
|
Depositary Receipt
|
+16.24% (+43.8K)
|
||||
|
|
Diageo PLC ADR
|
0.52%
|
$149.18
|
-43.58%($84.17)
|
2023 Q1
|
≈ 0.75 years
|
Depositary Receipt
|
+18.14% (+20.19K)
|
||||
|
|
Relx PLC ADR
|
0.51%
|
$33.70
|
-0.53%($33.52)
|
2021 Q1
|
≈ 2.75 years
|
Depositary Receipt
|
-23.07% (-171.48K)
|
||||
|
|
Takeda Pharmaceutical Co Ltd ADR
|
0.51%
|
$15.47
|
+10.76%($17.14)
|
2018 Q4
|
≈ 5.00 years
|
Depositary Receipt
|
+11.04% (+123.72K)
|
||||
Completely sold out
8 results
| History | Ticker | Name |
Sold shares* |
% change to portfolio |
Held since* | Held for* |
|---|---|---|---|---|---|---|
|
|
Canadian National Railway Company
|
-2,887,742
|
-9.21%
|
2021 Q4
|
≈ 1.75 years
|
|
|
|
WestRock Co
|
-2,111,676
|
-1.62%
|
2021 Q1
|
≈ 2.50 years
|
|
|
|
Leidos Holdings Inc
|
-558,903
|
-1.3%
|
2018 Q2
|
≈ 5.25 years
|
|
|
|
Tencent Music Entertainment Group
|
-6,052,922
|
-1.18%
|
2022 Q3
|
≈ 1.00 year
|
|
|
|
Carrier GlobalCorp
|
-754,096
|
-0.99%
|
2020 Q4
|
≈ 2.75 years
|
|
|
|
MercadoLibre Inc
|
-10,070
|
-0.31%
|
2023 Q2
|
≈ 0.25 years
|
|
|
|
YPF Sociedad Anonima
|
-791,539
|
-0.31%
|
2023 Q1
|
≈ 0.50 years
|
|
|
|
Wipro Limited ADR
|
-100,430
|
-0.01%
|
2013 Q4
|
≈ 9.75 years
|
|
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
* Current price: this can be a delayed price and may not reflect the real-time market value, however it is too close.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.
* Held since / Held for: calculated since the latest "new buy" position. If the security was previously exited and re-entered, only the most recent holding period is counted.